Clinical trials
Observational Cardiomyopathy, Hypertrophic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 9 |
| Active, not recruiting | 7 |
| Terminated | 4 |
| Unknown status | 3 |
| Enrolling by invitation | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 14 |
| Bristol-Myers Squibb | 6 |
| Mayo Clinic | 5 |
| The Cleveland Clinic | 4 |
| Johns Hopkins University | 2 |
| Prolaio | 2 |
| University of Virginia | 2 |
| Viz.ai, Inc. | 2 |
| Wayne State University | 2 |
| American Heart Association | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 60 |
| Cardiomyopathy, Dilated | 9 |
| Heart Failure | 7 |
| Cardiomegaly | 5 |
| Cardiomyopathies | 5 |
| Arrhythmias, Cardiac | 4 |
| Cardiomyopathy, Restrictive | 4 |
| Cardiovascular Diseases | 4 |
| Heart Diseases | 4 |
| Hypertrophy, Left Ventricular | 4 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.